Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...

A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

New blood test could improve survival rates of deadly cancer - Pancreatic cancer is the fifth most common cause of cancer ...

Hone Health reports that chronic inflammation is a key factor in heart disease risk often overlooked in standard health ...

A new blood test analyzes DNA fragments to screen for 50 types of cancer simultaneously. The $949 Galleri test detected ...

Most people assume diabetes is easy to diagnose. You take a blood test, get a number, and that’s it. But in real life, it’s ...

@hopkinskimmel researchers develop novel liquid biopsy approach to identifying early-stage cancers. › ...

A new blood test has been developed that could improve survival rates for pancreatic cancer, a disease frequently diagnosed ...

Technology created at the University of Queensland could improve the odds of surviving brain cancer and change how we treat a ...

Since many cancers don’t have symptoms early on, they may go unnoticed until they are at an advanced stage. But that is ...

It’s rare that people have a disorder where cortisol on its own is the cause. If a person’s cortisol level is chronically low ...